WINT
USDWindtree Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$0.648
High
$0.650
Low
$0.600
Volume
1.29M
Company Fundamentals
Market Cap
2.3M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
4.53M
Exchange
NCM
Currency
USD
52-Week Range
Related News
Windtree Receives Offer for Its Preclinical Oncology Drug Candidate
Company to receive $7.0 million up front for its preclinical oncology drug candidate Up to $130.0 million in milestone payments starting with initiation of Phase 1 High single digit royalties that could total up to
Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors
Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced the appointment of Saundra Pelletier, CEO of Evofem Biosciences, Inc.
Windtree Announces Plan for Cryptocurrency Treasury Policy
WARRINGTON, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing
Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025
Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the istaroxime cardiogenic shock
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.